Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
$ 18.725 0.275 (1.49%) Market Cap: 21.07 Bil Enterprise Value: 37.43 Bil PE Ratio: 0 PB Ratio: 3.31 GF Score: 59/100

Q4 2018 Teva Pharmaceutical Industries Ltd Earnings Call Transcript

Feb 13, 2019 / 01:00PM GMT
Release Date Price: $17.63 (-7.79%)
Operator

Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to today's Teva Pharmaceutical Industries Limited Fourth Quarter 2018 Results Conference Call. (Operator Instructions) I must remind you that this conference is being recorded today, Wednesday, the 13th of February, 2019.

And I would now like to hand the conference over to your first speaker today, Mr. Kevin Mannix, Senior Vice President, Investor Relations. Please go ahead.

Kevin C. Mannix
Teva Pharmaceutical Industries Limited - Head of Global IR & VP

Thank you, operator. Thank you, everyone, for joining us today to discuss Teva's fourth quarter and full year 2018 financial results. We hope you've had an opportunity to review our earnings press release, which was issued earlier this morning. A copy of this press release as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com as well as through our Teva Investor Relations app.

Please note that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot